Form 8-K - Current report:
SEC Accession No. 0001558370-24-012969
Filing Date
2024-09-24
Accepted
2024-09-23 17:44:22
Documents
17
Period of Report
2024-09-18
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rsls-20240918x8k.htm   iXBRL 8-K 39455
2 EX-3.1 rsls-20240918xex3d1.htm EX-3.1 12120
3 EX-99.1 rsls-20240918xex99d1.htm EX-99.1 8407
4 GRAPHIC rsls-20240918xex99d1001.jpg GRAPHIC 14775
  Complete submission text file 0001558370-24-012969.txt   213831

Data Files

Seq Description Document Type Size
5 EX-101.SCH rsls-20240918.xsd EX-101.SCH 3960
6 EX-101.DEF rsls-20240918_def.xml EX-101.DEF 2866
7 EX-101.LAB rsls-20240918_lab.xml EX-101.LAB 17221
8 EX-101.PRE rsls-20240918_pre.xml EX-101.PRE 10194
19 EXTRACTED XBRL INSTANCE DOCUMENT rsls-20240918x8k_htm.xml XML 4862
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Filer) CIK: 0001427570 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37897 | Film No.: 241317185
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)